The association of C-reactive protein and CRP genotype with coronary heart disease: Findings from five studies with 4,610 cases amongst 18,637 participants

PLoS ONE

Volumn 3, Issue 8, 2008, Pages

  Lawlor, Debbie A ^a   Harbord, Roger M ^a   Timpson, Nic J ^a   Lowe, Gordon D O ^b   Rumley, Ann ^b   Gaunt, Tom R ^a   Baker, Ian ^a   Yarnell, John W G ^c   Kivimäki, Mika ^d   Kumari, Meena ^d   Norman, Paul E ^e   Jamrozik, Konrad ^f   Hankey, Graeme J ^g   Almeida, Osvaldo P ^e   Flicker, Leon ^e   Warrington, Nicole ^h   Marmot, Michael G ^d   Ben Shlomo, Yoav ^a   Palmer, Lyle J ^a,h   Day, Ian N M ^a   Ebrahim, Shah ⁱ   Smith, George Davey ^a   more..

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

ⁱ LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOSINE; THYMINE;

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAUSAL ATTRIBUTION; CONFOUNDING VARIABLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SMOKING; SOCIAL STATUS; CORONARY ARTERY DISEASE; EPIDEMIOLOGY; GENETICS; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; C-REACTIVE PROTEIN; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORONARY DISEASE; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES;

EID: 51649121111     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003011     Document Type: Article

References (56)

1. Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T (2003) Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status. J Epidemiol Community Health 57: 730-733.
2. Davey Smith G, Lawlor DA, Harbord R, Rumley A, Lowe GDO, et al. (2005) Association of C-reactive protein with blood pressure and hypertension: lifecourse confounding and Mendelian randomisation tests of causality. Arteriosclerosis Thrombosis & Vascular Biology 25: 1051-1056.
3. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, et al. (2005) Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 26: 1765-1773.
4. Wannamethee SG, Lowe GD, Whincup PH, Rumley A, Walker M, et al. (2002) Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 105: 1785-1790.
5. Kivimaki M, Lawlor DA, Juonala M, Davey Smith G, Elovainio M, et al. (2005) Lifecourse socioeconomic position, C-reactive protein, and carotid intima-media thickness in young adults: the cardiovascular risk in Young Finns Study. Arterioscler Thromb Vasc Biol 25: 2197-2202.
6. Gimeno D, Brunner EJ, Lowe GDO, Rumley A, Marmot ME, et al. (2007) Adult socioeconomic position, C-reactive protein and interleukin-6 in the Whitehall II prospective study. European Journal of Epidemiology 22: 675-683.
7. Lowe GD (2005) Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 3: 1618-1627.
8. Davey Smith G, Ebrahim S (2003) "Mendelian randomisation": can genetic epidemiology contribute to understanding environmental determinants of disease? International Journal of Epidemiology 32: 1-22.
9. Davey Smith G (2006) Randomised by (your) god: robust inference from an observational study design. J Epidemiol Community Health 60: 382-388.
10. Lawlor DA, Harbord RM, Sterne JAC, Timpson NJ, Davey Smith G (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Statistics in Medicine 27: 1133-1163.
11. Davey Smith G, Timpson N, Lawlor DA (2006) C-reactive protein and cardiovascular disease risk: still an unknown quantity? Ann Intern Med 115: 70-72.
12. Casas JP, Shah T, Cooper J, Hawe E, McMahon AD, et al. (2006) Insights into the nature of the CRP-coronary event association using Medelian randomization. International Journal of Epidemiology 35: 922-934.
13. Pai JK, Mukamal KJ, Rexrode KM, Rimm EB (2008) C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies. PloS-One 3: e1395.doi10.1371/ journal.pone.0001395.
14. Suk HJ, Ridker PM, Cook NR, Zee RY (2005) Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 178: 139-145.
15. Zee RY, Ridker PM (2002) Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162: 217-219.
16. Miller DT, Zee RY, Suk DJ, Kozlowski P, Chasman DI, et al. (2005) Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 69: 623-638.
17. Kathiresan S, Larsen MG, Vasan RS, Guo CY, Gona P, et al. (2006) Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 113: 1415-1423.
18. Crawford DC, Sanders CL, Qui X, Smith JD, Shephard C, et al. (2006) Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 114: 2458-2465.
19. Lange LA, Carlson CS, Hindorff LA, Lange EM, Walston J, et al. (2006) Association of polymorphism in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 296: 2703-2711.
20. Hage FG, Szalai AJ (2007) C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol. 50: 1115-1122.
21. Kivimaki M, Lawlor DA, Davey Smith G, Kumari M, Donald A, et al. (2008) Does High C-reactive Protein Concentration Increase Atherosclerosis? The Whitehall II Study. PloS-One 2008.
22. Lawlor DA, Timpson N, Ebrahim S, Day IMN, Davey Smith G (2006) The association of estrogen receptor a haplotypes with cardiovascular risk factors in the British Women's Heart and Health Study. European Heart Journal 2006; 27: 1597-1604.
23. The Caerphilly and Speedwell Collaborative Group (1984) Caerphilly and Speedwell collaborative heart disease studies. Journal of Epidemiology & Community Health 38: 259-262.
24. Marmot MG, Davey Smith G, Stansfeld S, Patel C, North F, et al. (1991) Health inequalities among British civil servants: the Whitehall II study. Lancet 337: 1387-1393.
25. Jamrozik K, Norman PE, Spencer CA, Parsons RW, Tuohy R, et al. (2000) Screening for abdominal aortic aneurysm: lessons from a population-based study. Med J Aust 173: 345-350.
26. Rose GA, Blackburn H, Gillum RF, Prineas RJ (1982) Cardiovascular survey methods. Geneva: WHO.
27. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, et al. (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90: 583-612.
28. Holman CD, Bass AJ, Rouse IL, Hobbs MS (1999) Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health 23: 453-459.
29. D'Aiuto F, Casas JP, Shah T, Humphries SE, Hingorani AD, et al. (2005) C-reactive protein (+ 1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis 179: 413-417.
30. Brull DJ, Serrano N, Zito F, Jones L, Montgomery HE, et al. (2003) Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23: 2063-2069.
31. Carlson CS, Aldred SF, Lee PK, Tracy RP, Schwartz SM, et al. (2005) Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 77: 64-77.
32. Timpson NJ, Lawlor DA, Harbord RM, Gaunt TR, Day IN, et al. (2005) C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 366: 1954-1959.
33. Guo SW, Thompson EA (1992) Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48: 361-372.
34. Higgins JP, Thompson SG, Decks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
35. Danesh J, Collins R, Appleby P, Peto R (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279: 1477-1482.
36. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, et al. (2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321: 199-204.
37. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, et al. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350: 1387-1397.
38. Lowe GD, Pepys MB (2006) C-reactive protein and cardiovascular disease: weighing the evidence. Curr Atheroscler Rep 8: 421-428.
39. Kivimaki M, Lawlor DA, Davey Smith G, Eklund C, Hurme M, et al. (2007) Variants in the CRP Gene as a Measure of Life-long Differences in Average C-reactive Protein Levels: the Cardiovascular Risk in Young Finns Study. American Journal of Epidemiology 166: 760-764.
40. Hingorani A, Humphries S (2005) Nature's randomised trials. Lancet 366: 1906-1908.
41. Davey Smith G, Lawlor DA, Harbord R, Timpson N, Rumley A, et al. (2005) Association of C-reactive protein with blood pressure. Arteriosclerosis Thrombosis & Vascular Biology 25: e137-e138.
42. Davey Smith G, Lawlor DA, Harbord R, Timpson N, Day I, et al. (2008) Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PloS Medicine PLoS-Medicine 4: e352. doi:10.1371/journal.pmed.0040352.
43. Kovacs A, Green F, Hansson LO, Lundman P, Samnegard A, et al. (2005) A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 178: 193-198.
44. Szalai AJ, Wu J, Lange EM, McCrory MA, Langefeld CD, et al. (2005) Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med 83: 440-447.
45. Timpson NJ, Davey Smith G, Ebrahim S (2006) Letter by Timpson et al regarding article, "Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level". Circulation 114: e256.
46. The Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
47. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, et al. (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357: 443-453.
48. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberti R, et al. (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316: 1488-1491.
49. Sandhu MS, Waterworth DM, Debenham L, Wheeler E, Papadikis K. et-al. (2008) LDL-cholesterol concentrations: a genome-wide association study. Lancet 371: 483-491.
50. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH (2006) Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354: 1264-1272.
51. Brown MS, Goldstein JL (2006) Biomedicine. Lowering LDL-not only how low, but how long? Science 311: 1721-1723.
52. Davey Smith G, Ebrahim S (2004) Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 33: 30-42.
53. Freathy RM, Timpson NJ, Lawlor DA, Pouta A, Ben-Shlomo Y, et al. (2008) Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected, given its effect on BMI. Diabetes doi:10.2337/db07-1466.
54. Kivimaki M, Lawlor DA, Eklund C, Davey Smith G, Hurme M, et al. (2007) Mendelian randomization suggests no causal association between C-reactive protein and carotid intima-media thickness in the young Finns study. Arterioscler Thromb Vasc Biol 27: 978-979.
55. CRP CHD Genetics Collaboration (2008) Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomization. European Journal of Epidemiology dio:10.107/s10654-008-9249-z.
56. Pepys MB, Hirschfield GM, Tennent GA, Gallimore JR, Kahan MC, et al. (2006) Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440: 1217-1221.